Trial site
Lekarze Specjalisci - J. Malolepszy I Partnerzy
Wroclaw, Dolnoslaskie Voivodeship 54-239, PolandEU-13 widening countryNot linked to an institution yet
- 8running trials
- 9closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Phase
- Phase 28 trials
- Phase 38 trials
- Phase 41 trial
- Status
- Completed9 trials
- Active, not recruiting5 trials
- Not yet recruiting2 trials
- Recruiting1 trial
- Lead sponsor
- Chiesi Farmaceutici S.p.A.4 trials
- AstraZeneca3 trials
- Hoffmann-La Roche2 trials
- Kymera Therapeutics Inc.2 trials
- Upstream Bio Inc.2 trials
- and 4 more
Running trials
Not yet recruiting
A Randomized, Double-Blind, Placebo-controlled, Parallel Arm, 52-week Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Two Doses of EXPD-101 in Participants with COPD
2026-525216-34-00· Phase 2· Expedition Therapeutics Inc.· Source
Not yet recruiting
A Long-term Study of KT-621 Administered Orally to Participants with Asthma Previously Enrolled in a KT-621 Asthma Study
2026-526241-98-00· Phase 2· Kymera Therapeutics Inc.· Source
Recruiting
A Study of KT-621 Administered Orally to Adult Participants with Moderate to Severe Eosinophilic Asthma
2025-523180-38-00· Phase 2· Kymera Therapeutics Inc.· Source
Recruiting
Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
NCT07301736· Phase 2· Chiesi Farmaceutici S.p.A.· Source
Active, not recruiting
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
NCT06966479· Phase 2· Upstream Bio Inc.· Source
Active, not recruiting
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
NCT06572228· Phase 4· Regeneron Pharmaceuticals· Source
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
NCT06283966· Phase 3· AstraZeneca· Source
Active, not recruiting
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
NCT05878769· Phase 3· Hoffmann-La Roche· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error